Ghrelin in preterm and term newborns: relation to anthropometry, leptin and insulin

Pak C Ng1, Cheuk H Lee, Christopher W K Lam

  • 1Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong. pakcheungng@cuhk.edu.hk

Clinical Endocrinology
|August 3, 2005
PubMed

Insights

Plasma ghrelin levels are consistent at birth in both preterm and term newborns. In term infants, ghrelin inversely correlates with birth weight and length, suggesting a role in regulating infant metabolism.

Area of Science:

  • Neonatal physiology
  • Endocrinology
  • Metabolic regulation

Background:

  • Ghrelin is a key metabolic hormone influencing appetite and growth.
  • Understanding ghrelin's role in neonates is crucial for assessing early metabolic programming.
  • Preterm birth may impact early hormonal development and metabolic adaptation.

Purpose of the Study:

  • To determine plasma ghrelin concentrations at birth in preterm and term newborns.
  • To investigate the relationship between ghrelin, metabolic hormones (leptin, insulin), and anthropometric parameters.
  • To explore potential gestational age-related variations in neonatal ghrelin levels.

Main Methods:

  • Blood samples collected from preterm (n=81) and term (n=40) newborns within 2 hours of birth.
  • Hormonal assays performed for plasma ghrelin, leptin, and insulin.
  • Statistical analysis to evaluate correlations between ghrelin, hormones, and anthropometric data.

Main Results:

  • Plasma ghrelin was detectable in all infants, with no significant difference between preterm and term groups.
  • No overall correlation found between ghrelin and gestational age, anthropometry, leptin, or insulin.
  • In term infants only, ghrelin showed an inverse correlation with birth weight and body length.

Conclusions:

  • Neonatal plasma ghrelin concentrations are stable from 23 to 42 weeks gestation.
  • Ghrelin secretion does not appear to vary with gestational age at birth.
  • The inverse relationship in term infants suggests ghrelin's role in late-gestation growth and metabolism, potentially aiding appetite and glucose regulation post-birth.
Abstract

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...